Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 5 Rectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Head and Neck Neoplasms 4 Glioblastoma 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Glioma 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Brain Neoplasms 3 Astrocytoma 3 Recurrence 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Lung Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Hepatocellular 2 Wilms Tumor 1 Skin Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma 1 Rhabdomyosarcoma 1 Radiation Injuries 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Postoperative Complications 1

Interventions

Doxorubicin 14 pembrolizumab 11 Specimen Handling 11 Magnetic Resonance Spectroscopy 10 Biopsy 9 Cyclophosphamide 8 X-Rays 7 Radiotherapy 7 Nivolumab 7 Ifosfamide 7 Phantoms, Imaging 6 Gemcitabine 6 liposomal doxorubicin 5 Temozolomide 5 Radiation 5 tazemetostat 4 palbociclib 4 Trabectedin 4 Nuclear Medicine Department, Hospital 4 Irinotecan 4 Ipilimumab 4 pazopanib 3 larotrectinib 3 fludarabine 3 cabozantinib 3 atezolizumab 3 Surveys and Questionnaires 3 Radiation Dose Hypofractionation 3 Proton Therapy 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Surgical Procedures, Operative × 90 days × Clear all

NCT05950594 2026-03-16

IVIM & OLINK in Sarcoma

University Health Network, Toronto

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡